2022 Annual Meeting Virtual Experience | C21 - Neurology Case Conference: Neuroimmunology

Date Monday 04/25/22

Time 04:00 PM - 05:00 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Stephen Krieger, MD, FAAN

Moderator(s) Jonathan Graff-Radford, MD, FAAN

Topic(s) Multiple Sclerosis

Learning Objectives Learners will differentiate between treatment options for Multiple Sclerosis and construct prioritized treatments for different clinical scenarios.
Learners will discriminate between MS and related conditions in neuroimmunology on the basis of clinical presentation and neuroimaging nuances.
Learners will describe the challenge in distinguishing relapsing from progressive MS and be able to illustrate clinical course dynamically using the topographical model of MS

CME Available 1.00 CME credit

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
04:00 PM - 04:50 PM EDT	Speaker	Neurology Case Conference: Neuroimmunology Stephen Krieger, MD, FAAN, Michelle Fabian, MD, FAAN
04:50 PM - 05:00 PM EDT	Q&A	Live Questions and Answers Stephen Krieger, MD, FAAN, Michelle Fabian, MD, FAAN

Faculty Disclosures
Stephen Krieger, MD, FAAN	Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Expert Witness. The institution of Dr. Krieger has received research support from Novartis. The institution of Dr. Krieger has received research support from Bristol Myers Squibb. The institution of Dr. Krieger has received research support from Biogen.
Michelle Fabian, MD, FAAN	Dr. Fabian has nothing to disclose.
Jonathan Graff-Radford, MD, FAAN	Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics.

��ɫ��

��ɫ��